Citations for
1AMT, GCE2, GCE3, GLDC
Mutation analysis of glycine decarboxylase, aminomethyltransferase and glycine cleavage system protein-H genes in 13 unrelated families with glycine encephalopathy.
Azize NA, Ngah WZ, Othman Z, Md Desa N, Chin CB, Md Yunus Z, Mohan A, Hean TS, Syed Zakaria SZ, Lock-Hock N.
J Hum Genet 59(11):593-7. doi: 10.1038/jhg.2014.69. 2014
2AMT, GCE1, GCE2, GCE3, GCSH, GLDC
Two novel laboratory tests facilitating diagnosis of glycine encephalopathy (nonketotic hyperglycinemia).
Kure S.
Brain Dev 33(9):753-7. doi: 10.1016/j.braindev.2011.03.001. Review. 2011
3AMT, GCE1, GCE2, GCE3, GCSH, GLDC
Comprehensive mutation analysis of GLDC, AMT, and GCSH in nonketotic hyperglycinemia.
Kure S, Kato K, Dinopoulos A, Gail C, DeGrauw TJ, Christodoulou J, Bzduch V, Kalmanchey R, Fekete G, Trojovsky A, Plecko B, Breningstall G, Tohyama J, Aoki Y, Matsubara Y.
Hum Mutat 27(4):343-52. 2006
4GCE2, GLDC
A single nucleotide substitution that abolishes the initiator methionine codon of the GLDC gene is prevalent among patients with glycine encephalopathy in Jerusalem.
Boneh A, Korman SH, Sato K, Kanno J, Matsubara Y, Lerer I, Ben-Neriah Z, Kure S.
J Hum Genet 50(5):230-4. 2005
5GCE1, GCE2, GCSH, GLDC
Heterozygous GLDC and GCSH gene mutations in transient neonatal hyperglycinemia.
Kure S, Kojima K, Ichinohe A, Maeda T, Kalmanchey R, Fekete G, Berg SZ, Filiano J, Aoki Y, Suzuki Y, Izumi T, Matsubara Y.
Ann Neurol 52(5):643-6. 2002